Epsilon Healthcare (ASX:EPN) - Aandelenkoers, Nieuws & Analyse

EPN Overzicht aandelen

Epsilon Healthcare Limited operates as a healthcare and pharmaceuticals company primarily in Australia and Canada. Meer informatie

EPN fundamentele analyse
Sneeuwvlok Score
Waardering	2/6
Toekomstige groei	0/6
Prestaties in het verleden	0/6
Financiële gezondheid	2/6
Dividenden	0/6

Risicoanalyse

De winst is de afgelopen 5 jaar met 4.2% per jaar gedaald

Heeft geen betekenisvolle marktkapitalisatie ( A$7M )

Aandelen zijn zeer illiquide

Heeft minder dan 1 jaar cash runway

+ 1 meer risico

Epsilon Healthcare Limited Concurrenten

Cann Global

ASX:CGB

AU$5.4m

Avecho Biotechnology

ASX:AVE

AU$6.3m

Emyria

ASX:EMD

AU$14.5m

Ecofibre

ASX:EOF

AU$15.4m

Prijsgeschiedenis en prestaties

Overzicht van alle hoogtepunten, veranderingen en prijsdalingen voor Epsilon Healthcare
Historische aandelenkoersen
Huidige aandelenkoers	AU$0.024
52 Week Hoogtepunt	AU$0.034
52 Week Laag	AU$0.016
Bèta	0.92
11 maand verandering	0%
3 maanden verandering	0%
1 Jaar Verandering	20.00%
33 jaar verandering	-89.57%
5 jaar verandering	-95.60%
Verandering sinds IPO	-94.07%

Recent nieuws en updates

Recent updates

Rendement voor aandeelhouders

	EPN	AU Pharmaceuticals	AU Markt
7D	0%	-16.3%	0.9%
1Y	20.0%	35.0%	17.7%

Rendement versus industrie: EPN presteerde slechter dan de Australian Pharmaceuticals -sector, die het afgelopen jaar een rendement van 35 % opleverde.

Rendement versus markt: EPN overtrof de Australian markt, die het afgelopen jaar een rendement opleverde van 17.7 %.

Prijsvolatiliteit

Is EPN's price volatile compared to industry and market?
EPN volatility
EPN Average Weekly Movement	n/a
Pharmaceuticals Industry Average Movement	11.9%
Market Average Movement	8.5%
10% most volatile stocks in AU Market	17.2%
10% least volatile stocks in AU Market	3.3%

Stabiele aandelenkoers: EPN heeft de afgelopen 3 maanden geen significante prijsvolatiliteit gekend.

Volatiliteit in de loop van de tijd: Onvoldoende gegevens om de volatiliteitsverandering van EPN in het afgelopen jaar te bepalen.

Over het bedrijf

Opgericht	Werknemers	CEO	Website
2016	n/a	Daniel Sanghera	epsilonhealthcare.com.au

Epsilon Healthcare Limited Samenvatting

Hoe verhouden de winst en inkomsten van Epsilon Healthcare zich tot de beurswaarde?
EPN fundamentele statistieken
Marktkapitalisatie	AU$7.21m
Inkomsten(TTM)	-AU$5.93m
Inkomsten(TTM)	AU$7.21m

1.0x

P/S-verhouding

-1.2x

Koers/Winstverhouding

Is EPN overgewaardeerd?

Zie Reële waarde en waarderingsanalyse

Inkomsten en omzet

Belangrijkste winstgevendheidsstatistieken uit het laatste winstverslag (TTM)
EPN resultatenrekening (TTM)
Inkomsten	AU$7.21m
Kosten van inkomsten	AU$5.09m
Brutowinst	AU$2.12m
Overige uitgaven	AU$8.05m
Inkomsten	-AU$5.93m

Laatst gerapporteerde inkomsten

Jun 30, 2023

Volgende inkomensdatum

n.v.t.

Winst per aandeel (EPS)	-0.02
Brutomarge	29.46%
Nettowinstmarge	-82.17%
Schuld/Eigen Vermogen Verhouding	27.1%

Hoe presteerde EPN op de lange termijn?

Bekijk historische prestaties en vergelijking

EPN Overzicht aandelen

Risicoanalyse

Epsilon Healthcare Limited Concurrenten

ASX:CGB

AU$5.4m

ASX:AVE

AU$6.3m

ASX:EMD

AU$14.5m

ASX:EOF

AU$15.4m

Prijsgeschiedenis en prestaties

Recent nieuws en updates

Epsilon Healthcare Appoints Richard Legge as Company Secretary

Epsilon Healthcare Limited Announces Termination of Xiao (Josh) Cui as Company Secretary

Epsilon Healthcare Receive Notice from Watercrest Asset Management Pty Ltd

Epsilon Healthcare Receive Notice from Watercrest Asset Management Pty Ltd

Epsilon Healthcare Limited Announces Board Appointments

Epsilon Healthcare Limited Announces Terminates Peter Giannopoulos as Chief Executive Officer

Recent updates

Epsilon Healthcare Appoints Richard Legge as Company Secretary

Epsilon Healthcare Limited Announces Termination of Xiao (Josh) Cui as Company Secretary

Epsilon Healthcare Receive Notice from Watercrest Asset Management Pty Ltd

Epsilon Healthcare Receive Notice from Watercrest Asset Management Pty Ltd

Epsilon Healthcare Limited Announces Board Appointments

Epsilon Healthcare Limited Announces Terminates Peter Giannopoulos as Chief Executive Officer

Does Epsilon Healthcare (ASX:EPN) Have A Healthy Balance Sheet?

Non-Executive Deputy Chairman recently bought AU$67k worth of stock

First half 2023 earnings released: AU$0.002 loss per share (vs AU$0.035 loss in 1H 2022)

Non-Executive Deputy Chairman recently bought AU$55k worth of stock

Is Epsilon Healthcare (ASX:EPN) Using Too Much Debt?

New minor risk - Share price stability

Epsilon Healthcare Appoints Peter Giannopoulos as Chief Executive Officer, Effective 23 May, 2023

Full year 2022 earnings released: AU$0.066 loss per share (vs AU$0.048 loss in FY 2021)

Epsilon Healthcare Limited Announces Executive Changes

Epsilon Healthcare Limited Appoints Mark Audet as Chief Financial Officer

No independent directors

Epsilon Healthcare Limited Announces Resignation of Simon Rowe as Director

Epsilon Healthcare Limited Announces Board Changes

Epsilon Healthcare Limited Announces Resignation of Nicholas Marshall as Chief Financial Officer

Epsilon Healthcare Limited Announces Executive Changes

First half 2022 earnings released: AU$0.035 loss per share (vs AU$0.022 loss in 1H 2021)

Epsilon Healthcare Limited Announces Resignation of Dr. Rob Jenny as A Director

Epsilon Healthcare Limited Announces Resignation of Jarrod White as Chief Executive Officer

Epsilon Healthcare Limited Appoints Patrick Baiyu Xu as Director

Epsilon Healthcare Limited, Annual General Meeting, May 31, 2022

Epsilon Healthcare Limited announced that it expects to receive AUD 2.1 million in funding

No independent directors

Full year 2021 earnings released: AU$0.046 loss per share (vs AU$0.066 loss in FY 2020)

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Epsilon Healthcare Limited announced that it expects to receive AUD 2.898 million in funding from CPS Capital

First half 2021 earnings released: AU$0.022 loss per share (vs AU$0.039 loss in 1H 2020)

We Think Epsilon Healthcare (ASX:EPN) Has A Fair Chunk Of Debt

Epsilon Healthcare Limited (ASX:EPN) entered into binding heads of agreement to acquire AlternaMed Pty Ltd. from Cannvalate PTY LTD for AUD 4.3 million.

First half 2021 earnings released: AU$0.022 loss per share (vs AU$0.039 loss in 1H 2020)

Joint Company Secretary Philip Leighfield has left the company

Is Epsilon Healthcare (ASX:EPN) Weighed On By Its Debt Load?

Tetra Health Partners with Astrid Healthcare to Operates the Astrid Dispensary in South Yarra

Non Executive Director has left the company

Epsilon Healthcare Limited Announces Resignation of Gary Radcliff as Non-Executive Director

Is Epsilon Healthcare (ASX:EPN) Using Too Much Debt?

Full year 2020 earnings released: AU$0.069 loss per share (vs AU$0.088 loss in FY 2019)

THC Global Group Limited announced that it expects to receive AUD 2.75 million in funding

New 90-day high: AU$0.29

THC Global Group Limited Announces CEO Changes

First half earnings released

New 90-day low - AU$0.24

New 90-day low - AU$0.26

THC Global Group Limited (ASX:THC) completed the acqusition of Tetra Pty Ltd from Meta Growth Corp. (TSXV:META) and others.

New 90-day low - AU$0.27

THC Global Group Limited has completed a Follow-on Equity Offering in the amount of AUD 1.535 million.

Rendement voor aandeelhouders

Prijsvolatiliteit

Over het bedrijf

Epsilon Healthcare Limited Samenvatting

1.0x

-1.2x

Inkomsten en omzet